tailieunhanh - VAERS Table of Reportable Events Following Vaccination*

Oracle OpenWorld is the world’s largest information technology event dedicated to helping enterprises understand how to harness the power of information. The event provides a platform for Oracle customers, partners, and employees to discover, integrate, and promote hardware and software tools for business. Oracle solutions assist with database development, enterprise resource planning, and customer relationship and supply chain management. | VAERS Table of Reportable Events Following Vaccination Vaccine Toxoid Event and interval from vaccination Tetanus in any combination DTaP DTP DTP-Hib DT Td TT Tdap DTaP-IPV DTaP-IPV Hib DTaP-HepB-IPV A. Anaphylaxis or anaphylactic shock 7 days B. Brachial neuritis 28 days C. Any acute complications or sequelae including death of above events interval - not applicable D. Events described in manufacturer s package insert as contraindications to additional doses of vaccine interval - see package insert Pertussis in any combination DTaP DTP DTP-Hib Tdap P DTaP-IPV DTaP-IPV Hib DTaP-HepB-IPV A. Anaphylaxis or anaphylactic shock 7 days B. Encephalopathy or encephalitis 7 days C. Any acute complications or sequelae including death of above events interval - not applicable D. Events described in manufacturer s package insert as contraindications to additional doses of vaccine interval - see package insert Measles mumps and rubella in any combination MMR MR M MMRV R A. Anaphylaxis or anaphylactic shock 7 days B. Encephalopathy or encephalitis 15 days C. Any acute complications or sequelae including death of above events interval - not applicable D. Events described in manufacturer s package insert as contraindications to additional doses of vaccine interval - see package insert Rubella in any combination MMR MMRV MR R A. Chronic arthritis 42 days B. Any acute complications or sequelae including death of above event interval - not applicable C. Events described in manufacturer s package insert as contraindications to additional doses of vaccine interval - see package insert Measles in any combination MMR MMRV MR M A. Thrombocytopenic purpura 7-30 days B. Vaccine-strain measles viral infection in an immunodeficient recipient 6 months C. Any acute complications or sequelae including death of above events interval - not applicable D. Events described in manufacturer s package insert as contraindications to additional doses of vaccine interval - see package insert Oral Polio OPV